These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29845349)

  • 1. Alternative splicing and cancer metastasis: prognostic and therapeutic applications.
    Marzese DM; Manughian-Peter AO; Orozco JIJ; Hoon DSB
    Clin Exp Metastasis; 2018 Aug; 35(5-6):393-402. PubMed ID: 29845349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pre-mRNA splicing: when the spliceosome loses ground].
    Dujardin G; Daguenet É; Bernard DG; Flodrops M; Durand S; Chauveau A; El Khoury F; Le Jossic-Corcos C; Corcos L
    Med Sci (Paris); 2016 Dec; 32(12):1103-1110. PubMed ID: 28044974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic targeting of splicing in cancer.
    Lee SC; Abdel-Wahab O
    Nat Med; 2016 Sep; 22(9):976-86. PubMed ID: 27603132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative splicing: an emerging topic in molecular and clinical oncology.
    Pajares MJ; Ezponda T; Catena R; Calvo A; Pio R; Montuenga LM
    Lancet Oncol; 2007 Apr; 8(4):349-57. PubMed ID: 17395108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance.
    Wojtuszkiewicz A; Assaraf YG; Maas MJ; Kaspers GJ; Jansen G; Cloos J
    Expert Opin Drug Metab Toxicol; 2015 May; 11(5):673-89. PubMed ID: 25495223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disturbances of alternative splicing in cancer].
    Wiszomirska H; Piekiełko-Witkowska A; Nauman A
    Postepy Biochem; 2011; 57(3):257-65. PubMed ID: 22235651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of critical alternative splicing events and splicing factors in gastric cancer progression.
    Feng H; Jin Z; Liu K; Peng Y; Jiang S; Wang C; Hu J; Shen X; Qiu W; Cheng X; Zhao R
    J Cell Mol Med; 2020 Nov; 24(21):12667-12680. PubMed ID: 32939931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.
    Urbanski LM; Leclair N; Anczuków O
    Wiley Interdiscip Rev RNA; 2018 Jul; 9(4):e1476. PubMed ID: 29693319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA splicing, cell signaling, and response to therapies.
    Abou Faycal C; Gazzeri S; Eymin B
    Curr Opin Oncol; 2016 Jan; 28(1):58-64. PubMed ID: 26575690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and Regulation of Alternative Pre-mRNA Splicing.
    Lee Y; Rio DC
    Annu Rev Biochem; 2015; 84():291-323. PubMed ID: 25784052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental approaches to studying the nature and impact of splicing variation in zebrafish.
    Keightley MC; Markmiller S; Love CG; Rasko JE; Lieschke GJ; Heath JK
    Methods Cell Biol; 2016; 135():259-88. PubMed ID: 27443930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Alternative Splicing in Cancer: Regulatory Mechanism, Therapeutic Strategy, and Bioinformatics Application.
    Pan YJ; Liu BW; Pei DS
    DNA Cell Biol; 2022 Sep; 41(9):790-809. PubMed ID: 35947859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
    Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
    Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors.
    Scott LM; Rebel VI
    J Natl Cancer Inst; 2013 Oct; 105(20):1540-9. PubMed ID: 24052622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative Splicing: Expanding the Landscape of Cancer Biomarkers and Therapeutics.
    Bessa C; Matos P; Jordan P; Gonçalves V
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative splicing in cancers: From aberrant regulation to new therapeutics.
    Song X; Zeng Z; Wei H; Wang Z
    Semin Cell Dev Biol; 2018 Mar; 75():13-22. PubMed ID: 28919308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An amazing meeting arrangement on messenger RNA genes.
    Pederson T
    RNA; 2018 Mar; 24(3):259-261. PubMed ID: 29208705
    [No Abstract]   [Full Text] [Related]  

  • 18. mRNA splicing in trypanosomes.
    Preußer C; Jaé N; Bindereif A
    Int J Med Microbiol; 2012 Oct; 302(4-5):221-4. PubMed ID: 22964417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A saga of cancer epigenetics: linking epigenetics to alternative splicing.
    Narayanan SP; Singh S; Shukla S
    Biochem J; 2017 Mar; 474(6):885-896. PubMed ID: 28270561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pre-mRNA alternative splicing in cancer: functional impact, molecular mechanisms and therapeutic perspectives].
    Revil T; Shkreta L; Chabot B
    Bull Cancer; 2006 Sep; 93(9):909-19. PubMed ID: 16980234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.